Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Non-alcoholic Fatty Liver Disease 1Lung Neoplasms 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Metformin 35Clomiphene 11Letrozole 10Inositol 7Triptorelin Pamoate 5drospirenone and ethinyl estradiol combination 4Progesterone 4Folic Acid 4Ethinyl Estradiol 4Caloric Restriction 4drospirenone 3cetrorelix 3Spironolactone 3Estradiol 3Diet, Mediterranean 3Diet 3Cyproterone acetate, ethinyl estradiol drug combination 3Contraceptives, Oral 3Acupuncture Therapy 3adrenosterone 2Vitamin D 2Ultrasonography 2Thioctic Acid 2Therapeutics 2Sitagliptin Phosphate 2Simvastatin 2Pioglitazone 2Ovidrel 2Musculoskeletal Manipulations 2Hematologic Tests 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Polycystic Ovary Syndrome × Canagliflozin × Clear all
NCT06256289 2024-02-13

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

The First Affiliated Hospital of Shanxi Medical University

Phase 4 Unknown
50 enrolled

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡